Skip to main content

Table 3 CD4+ distribution, level of differentiation and Cancer stage among HIV + participants (n = 22)

From: HIV serostatus and tumor differentiation among patients with cervical cancer at Bugando Medical Centre

Tumor characteristic CD4+ count Total Mean CD4+ count ± SD 95% CI p-value
≤350 >350
Cellular differentiation       
Well 8 (66.7) 4 (33.3) 12 (100.0)    
Moderate 5 (62.5) 3 (37.5) 8 (100.0)    
Poor 2 (100.0) 0 (0) 2 (100.0)    
Total 15 (68.2) 7 (31.8) 22 (100.0)    
Overall CD4 count n = 22     315.0 ± 138.0   
Well differentiated n = 12     318.8 ± 148.0   
Moderately and poorly differentiated n = 10     310 ± 132.8   0.893*
Cancer stage       
Early stage ( IA-IIA) 5 (55.6) 4 (44.4) 9 (100.0) 385.8 ± 170.4 354.8-516.7 0.042**
Late stage (IIB-IVB) 10 (76.9) 3 (23.1) 13 (100.0) 266.2 ± 87.5 213.3-319.0  
Total 15 (68.2) 7 (31.8) 22 (100.0)    0.290 (Pearson)***
  1. Note: Number in brackets denotes%.
  2. * p-value from a t-test statistic comparing the mean CD4+ count between well differentiated and
  3. moderate and poorly differentiated tumor cell patients.
  4. ** p-value from a t-test statistic comparing the mean CD4+ count between early and late stage disease.
  5. ***p-value comparing women with CD4+ count ≤350/μL in early and late stage diseases.